Treating mucosal lesions with hyaluronan delivered from an adhering troche
AssigneeQuest Products, LLC
InventorJeffrey Haley
Life of this patent
Estimating the term…
Abstract
A troche comprising at least 5 mg hyaluronan, wherein the troche is adherent, and wherein hyaluronan is released from the troche, is used to treat mucositis, including stomatitis, vestibulitis, aphthous ulcerations, lichen planus and Behcet's syndrome. A method for treating or preventing mucositis in a patient is provided, comprising applying to a mucosal surface or a tooth or orthodontic brace of a patient in need thereof an adhering troche comprising at least 5 mg hyaluronan.
Claims16
A bilayer troche comprising from 5 mg to less than 250 mg hyaluronan, wherein the troche has a pressed powder adherent layer and a pressed powder non-adherent layer, wherein the non-adherent layer comprises 2 to 50% hyaluronan by weight of the non-adherent layer and a lubricating substance, and wherein, when held in a human mouth, hyaluronan is released from the troche, thereby treating mucositis.
Dependencies are inferred from the claim text.